Foot and Mouth Disease (FMD) Vaccine Market Report

Foot and Mouth Disease (FMD) Vaccine Market Analysis By Technique (Conventional and Emergency Vaccines), By Animal Type (Cattle, Sheep & Goat, Pigs, Others), And Segment Forecasts, 2016 - 2025

Published: October 2017  |  75 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-656-1

Industry Insights

The global foot and mouth disease (FMD) vaccine market size was valued at USD 1.5 billion in 2016 and is expected to grow at a CAGR of 8.1% over the forecast period. Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally. Livestock and zoonotic diseases are increasing over the past few decades owing to factors such as adverse climatic transformations and rapid globalization. Various initiatives undertaken by the government to mandate safe healthcare practices for livestock and companion animals are some of the key factors driving the veterinary vaccine industry, of which, FMD vaccines capture a significant share.

Most of the developed & developing countries have strict regulations to prevent outbreak of zoonotic diseases. Outbreaks of zoonotic diseases have a deteriorating impact on a country’s GDP. Various preventive measures undertaken by the government include maintaining adequate stock of vaccines with new strains and execution of affected animals.

India foot and mouth diseases vaccines market, by animal type, 2014 - 2025 (USD million)

India foot and mouth diseases vaccines market

Increasing demand for animal products such as milk, chicken, eggs, meat, & fabric products and technologically advanced equipment are some of the factors redefining the animal industry and attracting huge investment. Vaccination is one of the principal measures undertaken to minimize animal loss. Private animal business owners as well as governments face a huge threat of economic loss caused by slaughter of affected animals. FMD vaccine is crucial due to unavailability of a permanent cure and multitude ways in which contamination can occur.

Livestock, being one of the important GDP contributors in most of the developing countries, draws significant attention for animal healthcare practices. Government organizations in these countries are paying keen attention for the adoption of advanced medication and vaccination facilities to maintain a healthy livestock population. Strict rules and regulations for international transportation of animal and animal products have helped in minimizing the risk of FMD outbreaks in developed countries of North America and Europe. As a result, currently, there is no demand for these vaccines in these regions.

Technique Insights

Conventional vaccines accounted for the largest segment in the global FMD diseases market in 2016. Rising adoption of oil-based vaccines owing to their longer period of effectiveness and higher efficacy is contributing to the dominance of the conventional vaccines segment. Although there are other conventional vaccines available, which are effective in preventing clinical diseases, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Regions that have successfully eradicated this disease, such as North America and Europe, have a repository of the most effective strains of these vaccines. These strains are stored for emergencies to save various species of animals. In case of widespread and sudden outbreaks of foot & mouth disease, these strains are used to prepare vaccines for immunizing animals. The emergency vaccines segment is expected to grow at a fastest rate during the forecast period owing to the above-mentioned factors.

Animal Type Insights

The cattle segment constitutes of domestic cattle such as cows, buffaloes, and bulls. FMD in cattle is one of the major contagious diseases. It is a threat to the worldwide cattle population and has been a reason for major economic losses. The U.S. successfully eradicated this disease in 1929; however, many countries are still fighting against this problem. Campaigns by the OIE (World Organization for Animal Health) such as the Southeast Asia Foot and Mouth Disease Campaign (SEAFMDC) are expected to boost the market growth.

In addition, sheep have often been responsible for the dissemination of disease virus globally. Some of the reported cases include introduction of FMD in Canada by sheep imported from the UK in 1857 and type A epidemic in Morocco in 1978 & 1983. FMD in sheep has been observed to be clinically silent. Excreta of infected sheep contains significantly high levels of FMD virus. As a result, maximum cross-contamination by sheep occurs through excreta and aero genic route. In addition, sheep products such as frozen lamb & other unprocessed sheep products are the primary factors responsible for transmittance of FMD virus across the borders, thereby contributing to increase in outbreak of the disease globally. The segment is expected to grow at the fastest rate during the forecast period.

Global foot and mouth diseases market revenue, by animal type, 2016 (%)

Global foot and mouth diseases vaccines market

Regional Insights

Asia Pacific region dominated the market in 2016. Presence of countries with larger livestock population and major market players are some of the few factors anticipated to contribute to the larger market share of the region. In addition, the market is driven by consistent efforts of market players to commercialize veterinary vaccines and increase in investment on R&D. Moreover, the urgent need to curb high incidence of this disease is expected to propel the market over the forecast period.

Currently there is no need for vaccination in North America as there are no reported cases of outbreak in the region since 1929. There is no chance of a viable virus being present in the region, hence, regular vaccination is not required. However, the antigen for FMD vaccine is maintained at The North America FMD Vaccine Bank, a facility at Foreign Animal Disease Diagnostic Laboratory. The objective of the laboratory is to monitor, store, and conduct R&D of vaccines & therapeutic options for highly contagious diseases similar to FMD. The facility monitors FMD disease outbreaks around the world and develops antigens for most active virus strains.

Competitive Insights

The global market is highly competitive. Key participants include Agrovet; Biogénesis Bago; Empresa Colombiana de Productos Veterinarios S.A. Vecol S.A.; FGBI - Federal Centre for Animal Health; Indian Immunologicals Limited; Merial (France); Veterinary Serum and Vaccine Research Institute; FMD Center; and Limor de Colombia.

Key parameters influencing competitive nature are rapid adoption of advanced treatment options for improved healthcare coupled with rising need for optimum capital utilization. In addition, in an attempt to retain share and diversify their product portfolio, major players are frequently practicing strategic collaboration with government.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2025

Market representation                                                

Revenue in USD million and CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, UK, Germany, China, India, South Korea, Japan, Malaysia, Mexico, Brazil, South Africa

Report coverage             

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments covered in the report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global foot and mouth diseases vaccine market based on technique, animal type and region:

  • Technique Outlook (Revenue, USD Million, 2014 - 2025)

    • Conventional Vaccines

      • Aluminum Hydroxide/Saponin-based Vaccines

      • Oil-based Vaccines

    • Emergency Vaccines

  • Animal Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Cattle

    • Sheep and goat

    • Pigs

    • Others (antelope, deer, bison and camelids)

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

    • Europe

    • Asia Pacific

      • India

      • China

      • Japan

      • South Korea

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

      • Nigeria

      • Saudi Arabia

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User - $5,950
Library Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA